Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China SXT Pharmaceuticals (SXTC) Current Deferred Tax Assets (2018 - 2021)

China SXT Pharmaceuticals has reported Current Deferred Tax Assets over the past 3 years, most recently at $504522.0 for Q3 2021.

  • For Q3 2021, Current Deferred Tax Assets fell 4.87% year-over-year to $504522.0; the TTM value through Sep 2021 reached $504522.0, down 4.87%, while the annual FY2021 figure was $547807.0, 7.28% up from the prior year.
  • Current Deferred Tax Assets for Q3 2021 was $504522.0 at China SXT Pharmaceuticals, down from $547807.0 in the prior quarter.
  • Over five years, Current Deferred Tax Assets peaked at $547807.0 in Q1 2021 and troughed at $46508.0 in Q3 2018.
  • A 3-year average of $427965.2 and a median of $510617.0 in 2020 define the central range for Current Deferred Tax Assets.
  • On a YoY basis, Current Deferred Tax Assets climbed as much as 7.28% in 2021 and fell as far as 4.87% in 2021.
  • Year by year, Current Deferred Tax Assets stood at $46508.0 in 2018, then soared by 1040.39% to $530372.0 in 2020, then dropped by 4.87% to $504522.0 in 2021.
  • Business Quant data shows Current Deferred Tax Assets for SXTC at $504522.0 in Q3 2021, $547807.0 in Q1 2021, and $530372.0 in Q3 2020.